TITC:ATHEXTitan S.A. Analysis
Data as of 2026-05-25 - not real-time
€47.22
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Titan S.A. is trading just below its 20‑day moving average at €47.22, with a bullish longer‑term trend but a bearish MACD histogram and decreasing volume indicating short‑term pressure. The RSI sits around the midpoint, while the stock’s beta of ~0.8 and 30‑day volatility of roughly 38% point to moderate market sensitivity and heightened price swings. Fundamentally, the company posts a PE of about 15 and a forward PE near 9.5, suggesting the current price may be undervalued relative to its earnings outlook.
The first‑quarter 2026 update highlighted a 4.7% like‑for‑like sales increase to €636 million and strong profitability, reinforcing the upside narrative. With a dividend yield of 2.33% and a payout ratio around 31%, the dividend appears sustainable. Margins remain solid, debt‑to‑equity is moderate at ~51%, and the forward earnings trajectory supports a value‑blend positioning for medium‑ to long‑term investors.
The first‑quarter 2026 update highlighted a 4.7% like‑for‑like sales increase to €636 million and strong profitability, reinforcing the upside narrative. With a dividend yield of 2.33% and a payout ratio around 31%, the dividend appears sustainable. Margins remain solid, debt‑to‑equity is moderate at ~51%, and the forward earnings trajectory supports a value‑blend positioning for medium‑ to long‑term investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and decreasing volume
- Price near short‑term support level
- Neutral RSI indicating limited upside momentum
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward PE of ~9.5 indicating valuation upside
- Strong Q1 sales growth and profitability
- Sustainable dividend yield above 2%
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Stable cash generation and moderate leverage
- Diversified geographic footprint reducing single‑market risk
- Consistent dividend policy supporting total return
Key Metrics & Analysis
Financial Health
Revenue Growth-0.40%
Profit Margin9.62%
P/E Ratio15.0
ROE12.82%
ROA7.23%
Debt/Equity51.46
P/B Ratio1.8
Technical Analysis
TrendBullish
RSI48.1
Support€45.26
Resistance€52.35
MA 20€47.63
MA 50€46.69
MA 200€44.83
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
GradeUndervalued
TypeBlend
Dividend Yield2.33%
Risk Assessment
Beta0.81
Volatility37.67%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.